1
2 Page 2 of 20
34...20
This case-based self-assessment activity outlines evaluation and treatment of extremity injury, plus new clinical and technical skills to improve delivery of healthcare to patients with upper and/or lower extremity trauma.
Member: $149.00
Non-Member: $249.00
5.00 AAPA Category 1 Self-Assessment CME credit
In both infants and older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities. While young children also have increased risk of morbidity and mortality due to pneumonia, it is not to the same extent as seen in older adults. The most recent guidance for vaccination practices was provided by the Center for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) in 2019. Since then, there have been several key changes in pneumococcal vaccination. These key updates include the approval of two pneumococcal vaccines in adults and new pediatric vaccination data. Clinicians treating those at risk of pneumococcal pneumonia and invasive pneumococcal disease (IPD) require increased education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, and updated information on recent approvals and evidence.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 CME credit
In both infants and older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities. While young children also have increased risk of morbidity and mortality due to pneumonia, it is not to the same extent as seen in older adults. The most recent guidance for vaccination practices was provided by the Center for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) in 2019. Since then, there have been several key changes in pneumococcal vaccination. These key updates include the approval of two pneumococcal vaccines in adults and new pediatric vaccination data. Clinicians treating those at risk of pneumococcal pneumonia and invasive pneumococcal disease (IPD) require increased education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, and updated information on recent approvals and evidence.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 Self-Assessment CME credit
At the onset of the pandemic, patients with suspected COVID-19 infection and with typical symptoms were treated as having COVID-19 even in the absence of positive test results. However, at this point, given the availability of testing in the United States, the Centers for Disease Control (CDC) and Infectious Diseases Society of America (IDSA) recommend SARS-CoV-2 testing where available. Current treatments for the outpatient treatment COVID-19 have garnered much attention in the medical community and the broader media. Many treatments are not supported by available evidence or carry a risk profile that may not warrant their use. Given the difficulty in outpatient administration of IV or subcutaneous monoclonal antibodies, researchers have been working towards the oral treatment of COVID-19. Several candidates are in late-stage clinical trials, with some emerging clinical data. As such, providers require an educational program that broadly encompasses the testing and treatment of COVID-19, so they will be able to properly counsel patients.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 CME credit
At the onset of the pandemic, patients with suspected COVID-19 infection and with typical symptoms were treated as having COVID-19 even in the absence of positive test results. However, at this point, given the availability of testing in the United States, the Centers for Disease Control (CDC) and Infectious Diseases Society of America (IDSA) recommend SARS-CoV-2 testing where available. Current treatments for the outpatient treatment COVID-19 have garnered much attention in the medical community and the broader media. Many treatments are not supported by available evidence or carry a risk profile that may not warrant their use. Given the difficulty in outpatient administration of IV or subcutaneous monoclonal antibodies, researchers have been working towards the oral treatment of COVID-19. Several candidates are in late-stage clinical trials, with some emerging clinical data. As such, providers require an educational program that broadly encompasses the testing and treatment of COVID-19, so they will be able to properly counsel patients.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 Self-Assessment CME credit
Post-COVID-19 Neurologic Syndrome: Another Legacy of the Pandemic | Vaping: The Gen Z Nicotine Crisis
Member: $0.00
Non-Member: $25.00
1.00 AAPA Category 1 CME credit
PAOS Ortho in the West 2022 Bundle offers up to 16.5 AAPA Category 1 CME credits and 5 AAPA Category 1 Self-Assessment CME credits including topics on common fractures, dislocations, and bone tumors to decreasing length of stay, and more, all on demand. This is the perfect course for advanced knowledge on the diagnosis and management of many musculoskeletal conditions.
Member: $299.00
Non-Member: $449.00
21.50 AAPA Category 1 CME credit
From common fractures, dislocations, and bone tumors to decreasing length of stay, and more, all on demand.
Member: $249.00
Non-Member: $399.00
16.50 AAPA Category 1 CME credit
This case-based self-assessment activity outlines evaluation and treatment of extremity injury, plus new clinical and technical skills to improve delivery of healthcare to patients with upper and/or lower extremity trauma.
Member: $149.00
Non-Member: $249.00
5.00 AAPA Category 1 Self-Assessment CME credit
The COVID-19 pandemic has impacted healthcare directly through high mortality and hospitalizations, but also in many indirect ways not fully appreciated. Routine preventative healthcare measures are key to modern healthcare systems, but they have been pushed aside during these trying times. Routine vaccinations, such has influenza and various pediatric immunizations, have decreased markedly during this pandemic. This activity addresses strategies and practices to help support appropriate vaccination administration as we all continue to be impacted by the COVID-19 pandemic.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 CME credit
1
2 Page 2 of 20
34...20